Share this article
Share this article
ATLANTA, Feb. 9, 2021 /PRNewswire/ Covanos, Inc., a privately-held medical technology company that is developing C-HEART, a PC-based software product that uses proprietary advances in computational fluid dynamics to rapidly and non-invasively diagnose the severity of coronary artery blockages, today announced that it has named Mark D. Carlson, MD, MA to the position of Senior Vice President and Chief Medical Officer. We are pleased to welcome Mark Carlson to the Covanos team, said Russell M. Medford, M.D., Ph.D., chairman and chief executive officer of Covanos. Mark s executive experience in developing and commercializing cardiac medical technology for some of the largest global businesses in the field positions Covanos well as we transition to a commercial enterprise later this year and pursue our mission to serve patients and reduce global healthcare costs.
The vaccine rollout has been slow and complicated, but you can help Here s how people are volunteering
newsindiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsindiatimes.com Daily Mail and Mail on Sunday newspapers.
Vaccine volunteers: How people have signed up to volunteer at coronavirus vaccination sites
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.